Skip to main content

. 1962 Sep;21(3):295–297. doi: 10.1136/ard.21.3.295

Failure of Relaxin in the Treatment of Scleroderma

J E Jefferis ¹, A St J Dixon ¹

PMCID: PMC1007291 PMID: 14028943

295

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CASTEN G. G., BOUCEK R. J. Use of relaxin in the treatment of scleroderma. J Am Med Assoc. 1958 Jan 25;166(4):319–324. doi: 10.1001/jama.1958.02990040005002. [DOI] [PubMed] [Google Scholar]
ISMAY G. Relaxin: its effects in a case of acrosclerosis. Br J Dermatol. 1958 May;70(5):171–175. doi: 10.1111/j.1365-2133.1958.tb13312.x. [DOI] [PubMed] [Google Scholar]
PERKOFF G. T., SALHANICK H. A., ZARROW M. X., NELSON D. H., TYLER F. H. Effects of administration of relaxin to human subjects. J Clin Endocrinol Metab. 1954 May;14(5):531–539. doi: 10.1210/jcem-14-5-531. [DOI] [PubMed] [Google Scholar]
SCOTT J. T., HOURIHANE D. O., DOYLE F. H., STEINER R. E., LAWS J. W., DIXON A. S., BYWATERS E. G. Digital arteries in rheumatoid disease. Ann Rheum Dis. 1961 Sep;20:224–234. doi: 10.1136/ard.20.3.224. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES